These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3705967)

  • 21. Commentary on AAPS Workshop: dissolution testing for the twenty-first century: linking critical quality attributes and critical process parameters to clinically relevant dissolution.
    Tong C; D'Souza SS; Parker JE; Mirza T
    Pharm Res; 2007 Sep; 24(9):1603-7. PubMed ID: 17385013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local controlled drug delivery to the brain: mathematical modeling of the underlying mass transport mechanisms.
    Siepmann J; Siepmann F; Florence AT
    Int J Pharm; 2006 May; 314(2):101-19. PubMed ID: 16647231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surfactants in dosage forms and biological systems. Part II].
    Eros I
    Acta Pharm Hung; 2005; 75(3):161-7. PubMed ID: 16318240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biopharmaceutical evaluation of preparations intended for the parenteral route].
    Aiache JM; Aiache S
    Boll Chim Farm; 1983 May; 122(5):213-28. PubMed ID: 6357232
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of in vitro dissolution of proprietary methyl dopa preparations.
    Morton DJ
    Cent Afr J Med; 1988 Jan; 34(1):7-9. PubMed ID: 3219716
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
    Kortejärvi H; Urtti A; Yliperttula M
    Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on dissolution test in vitro and bioavailability of oral osmotic pump of verapamil hydrochloride].
    Guo JL; Jing GW; Cao DS; Li YQ; He HY; Ling LX; Li Z
    Yao Xue Xue Bao; 1993; 28(9):714-20. PubMed ID: 8010021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory aspects of drug dissolution from a European perspective.
    Graffner C
    Eur J Pharm Sci; 2006 Nov; 29(3-4):288-93. PubMed ID: 16950606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro biopharmaceutical test for wetting rate.
    Plachy J; Rácz I; Zajta V
    Acta Pharm Hung; 1985 Jul; 55(4):212-6. PubMed ID: 4050448
    [No Abstract]   [Full Text] [Related]  

  • 30. Analytical, biopharmaceutical and regulatory evaluation of topical testosterone preparations.
    Baert B; Annavarapu S; Burvenich C; De Spiegeleer B
    Eur J Pharm Biopharm; 2009 May; 72(1):275-81. PubMed ID: 19026745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partitioning phenomena in dosage form and biopharmaceutical design. II. Some partitioning considerations in dosage form design.
    Schumacher GE
    Am J Hosp Pharm; 1971 Dec; 28(12):985-8. PubMed ID: 5135196
    [No Abstract]   [Full Text] [Related]  

  • 32. Automated simultaneous triple dissolution profiles of two drugs, sulphamethoxazole-trimethoprim and hydrochlorothiazide-captopril in solid oral dosage forms by a multicommutation flow-assembly and derivative spectrophotometry.
    Tomsů D; Catalá Icardo M; Martínez Calatayud J
    J Pharm Biomed Anal; 2004 Nov; 36(3):549-57. PubMed ID: 15522529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro biopharmaceutical control of pharmaceuticals. 5. Comparative dissolution of oral preparations containing acetylsalicylic acid by both periodical sampling and automatic procedure].
    Keserü P; Paál T; Varsányi L; Nagy P; Kissné Csikós E
    Acta Pharm Hung; 1985 Sep; 55(5):168-79. PubMed ID: 4061086
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of different variables on the in vitro dissolution of a theophylline sustained-release preparation].
    Fuchs WS; Jakobs R; Grunenberg P; Weiss G; Profitlich T; von Nieciecki A; Klemm FH; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):552-6. PubMed ID: 9676343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media.
    Sunesen VH; Pedersen BL; Kristensen HG; Müllertz A
    Eur J Pharm Sci; 2005 Mar; 24(4):305-13. PubMed ID: 15734297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mathematical evaluation of the dissolution of metronidazole from tablets.
    Deák D; Pintye-Hódi K; Szabó-Révész P; Kása P; Erós I; Muskó Z
    Pharmazie; 2000 May; 55(5):394-5. PubMed ID: 11828626
    [No Abstract]   [Full Text] [Related]  

  • 37. Analytical derivation of time required for dissolution of monodisperse drug particles.
    Sertsou G
    J Pharm Sci; 2004 Aug; 93(8):1941-4. PubMed ID: 15236444
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro assessment of dissolution kinetics: description and evaluation of a column-type method.
    Langenbucher F
    J Pharm Sci; 1969 Oct; 58(10):1265-72. PubMed ID: 5349118
    [No Abstract]   [Full Text] [Related]  

  • 39. [Optimization of spansule production by mathematical planning of an experiment].
    Muraviev IA; Ponomarev VD; Aslanov GK
    Farmatsiia; 1972; 21(3):40-2. PubMed ID: 5035642
    [No Abstract]   [Full Text] [Related]  

  • 40. The dissolution times of spherical particles.
    Ridgway K; Peacock DG
    J Pharm Pharmacol; 1971 Dec; 23():121S-131S. PubMed ID: 4401446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.